Effect of Venlafaxine, Pramipexole, and Valsartan on Spermatogenesis in Male Rats
Sign Up to like & getrecommendations! Published in 2020 at "ACS Omega"
DOI: 10.1021/acsomega.0c02587
Abstract: The study’s aim was to explore the effect of venlafaxine, valsartan, and pramipexole on spermatogenesis. It was hypothesized that these drugs may affect the male fertility because of their long-term use in treatment of depression,… read more here.
Keywords: spermatogenesis; venlafaxine; effect; pramipexole ... See more keywords
Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study
Sign Up to like & getrecommendations! Published in 2021 at "Parkinson's Disease"
DOI: 10.1155/2021/8834950
Abstract: Objective To explore the efficacy and safety of pramipexole sustained release (SR) versus pramipexole immediate release (IR) in treating nocturnal symptoms in levodopa-treated Chinese patients with advanced Parkinson's disease (PD) and sleep disturbances. Method SUSTAIN… read more here.
Keywords: safety; nocturnal symptoms; pramipexole; chinese patients ... See more keywords
Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study
Sign Up to like & getrecommendations! Published in 2019 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s205933
Abstract: Objective Some lines of evidence show that D2/D3 receptor partial agonist pramipexole may be effective in the treatment of extrapyramidal symptoms (EPS) and psychiatric symptoms of schizophrenia. Therefore, we analyzed whether a low dose of… read more here.
Keywords: study; symptoms schizophrenia; partial agonist; low dose ... See more keywords